Global Iron Deficiency Anemia Market By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion), By Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel Disease and Others), By Patient (Adults, Geriatric, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialty Clinics, Home Care Setting and Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 141779
- Number of Pages: 373
- Format:
-
-
-
- AbbVie Inc. Company Profile
- Akebia Therapeutics Inc.
- AMAG Pharmaceuticals Inc. (Covis Group S.à r.l.)
- Daiichi Sankyo Company
- Pharmacosmos A/S
- Sanofi S.A.
- Johnson & Johnson
- Fresenius SE & Co. KGaA
- CSL Vifor
- Rockwell Medical, Inc.
- Akorn Operating Company LLC
- Shield Therapeutics plc
- AdvaCare Pharma
- Otsuka Pharmaceutical Co., Ltd.
- Sun Pharmaceutical Industries Ltd.
- Other key players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible